Figure 1.
Depiction of possible instigators, actors and effectors of inflammation that could contribute to both vascular changes and poor outcomes in patients with delayed deterioration associated with vasospasm (DDAV) after aneurismal SAH.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.